LSTA vs WST · $31.7M cap vs P/E 35, rev $1.72B
Lisata Therapeutics Inc. (LSTA) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
Lisata Therapeutics Inc. (LSTA) is a biotechnology company listed on US.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported LSTA revenue for 2026-06-30 was $0. Net income was -$7.4M. LSTA currently screens at market cap $31.7M.
Latest reported WST revenue for 2026-06-30 was $1.72B. Net income was $292.8M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
LSTA currently screens at market cap $31.7M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the LSTA and WST stock pages for the full models.
Not investment advice.